Cited by 696Cancer survivorship and careCancer-related cognitive impairment studiesHealth Systems, Economic Evaluations, Quality of Life

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Measuring quality of life in men with prostate cancer using the Functional Assessment of Cancer Therapy-prostate instrument

Esper, Peg, Mo, Fei, Chodak, Gerald, Sinner, Michael, Cella, David, Pienta, Kenneth J.·1997·Urology

DOI 10.1016/s0090-4295(97)00459-7

Open this paper in CoChat — free account

Abstract

Objectives As the incidence of prostate cancer in the United States exceeds 330,000 in 1997, increasingly more men are faced with treatment choices for which there is no clear approach. At every stage of disease, these treatment choices may involve clinically equivalent modalities that differ in side effects and impact upon quality of life (QOL). Comprehensive, yet efficient, questionnaires are needed to measure QOL in patients with prostate cancer.Methods Developed as a disease-specific adjunct to the Functional Assessment of Cancer Therapy (FACT) measurement system, a 12-item prostate cancer subscale (PCS) was developed and tested in three independent samples: a subscale development sample (n = 43), validity sample 1 (n = 34), and validity sample 2 (n = 96). The 12 items ask about symptoms and problems specific to prostate cancer. These questions are added to the general (FACT-G) instrument, thereby comprising a 47-item questionnaire.Results Internal consistency of the PCS ranged from 0.65 to 0.69, with coefficients for FACT-G subscales and aggregated scores ranging from 0.61 to 0.90. Concurrent validity was confirmed by the ability to discriminate patients by disease stage, performance status, and baseline prostate-specific antigen (PSA) level. Sensitivity to change in performance status and PSA score over a 2-month period suggested that some subscales of the FACT-Prostate (P) (including the PCS) are sensitive to meaningful clinical change.Conclusions Our findings support use of the FACT-P as a meaningful component of QOL evaluation in men undergoing therapy for prostate cancer.

Integrity signals

Registry

Crossref · 10.1016/s0090-4295(97)00459-7

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

The functional assessment of cancer therapy scale: development and validation of the general measure
Cella, D. F., Tulsky, D. S., Gray, G., Sarafian, B., Linn, E., Bonomi, A., Silberman, M., Yellen, S. B., Winicour, P., & Brannon, J. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.3.570 · Cited by 6,020
Self-citation
Cancer statistics, 1997
Parker, S. L., Tong, T., Bolden, S., & Wingo, P. A. (1997) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.47.1.5 · Cited by 2,000
Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points.
Tannock, I. F., Osoba, D., Stockler, M. R., Ernst, D. S., Neville, A. J., Moore, M. J., Armitage, G. R., Wilson, J. J., Venner, P. M., Coppin, C., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.6.1756 · Cited by 1,575
Quality-of-life outcomes in men treated for localized prostate cancer
Litwin, M. S., Hays, R. D., Fink, A., Ganz, P. A., Leake, B., Leach, G. E., & Brook, R. H. (1995) · JAMA · doi:10.1001/jama.1995.03520260051032 · Cited by 1,020
Reliability and validity of the functional assessment of cancer therapy—lung (FACT-L) quality of life instrument
Cella, D. F., Bonomi, A. E., Lloyd, S. R., Tulsky, D. S., Kaplan, E. J., & Bonomi, P. (1995) · Lung Cancer · doi:10.1016/0169-5002(95)00450-f · Cited by 750
Self-citation
Treatment of metastatic prostatic cancer with low-dose prednisone: evaluation of pain and quality of life as pragmatic indices of response.
Tannock, I. F., Gospodarowicz, M., Meakin, W., Panzarella, T., Stewart, L., & Rider, W. D. (1989) · Journal of Clinical Oncology · doi:10.1200/jco.1989.7.5.590 · Cited by 407
Quality-of-life outcomes in men treated for localized prostate cancer
Litwin, M. S. (1995) · JAMA · doi:10.1001/jama.273.2.129 · Cited by 281
The association of benign prostatic hyperplasia and cancer of the prostate
Bostwick, D. G., Cooner, W. H., Denis, L., Jones, G. W., Scardino, P. T., & Murphy, G. P. (1992) · Cancer · doi:10.1002/1097-0142(19920701)70:1+ · Cited by 222
Early Detection of Prostate Cancer
Scardino, P. T. (1989) · Urologic Clinics of North America · doi:10.1016/s0094-0143(21)01800-0 · Cited by 210
Quality of Life and Functional Status Measures in Patients With Head and Neck Cancer
DʼAntonio, L. L., Zimmerman, G. J., Cella, D. F., & Long, S. A. (1996) · Archives of Otolaryngology - Head and Neck Surgery · doi:10.1001/archotol.1996.01890170018005 · Cited by 197
Self-citation

Show all 22 references

Research works printed but not linked: 2

da Silva, 1993, Quality of life in patients with prostatic cancer. A feasibility study, Cancer, 71, 1138, 10.1002/1097-0142(19930201)71:3+<1138::AID-CNCR2820711436>3.0.CO;2-7 · DOI
Esper, 1995, FACT-P: a new instrument for quality of life evaluation in prostate cancer (abstract), J Urol, 153

Sorted by citations

Items 201–300 of 696

A Review of Quality-of-Life Evaluations in Prostate Cancer
Sommers, S. D., & Ramsey, S. D. (1999) · PharmacoEconomics · doi:10.2165/00019053-199916020-00002 · Cited by 39
“It is available in 8 languages, and although its validity and reliability have been established, studies reporting its use in clinical settings beyond development have yet to be published.[41]”
Background
Depression and quality of life in cancer survivors: is there a relationship with physical activity?
Humpel, N., & Iverson, D. C. (2007) · International Journal of Behavioral Nutrition and Physical Activity · doi:10.1186/1479-5868-4-65 · Cited by 39
“The psychometric properties of the FACT scales are well documented [32,33] and have been found appropriate for use in cancer clinical trials.”
A pilot randomized trial of conventional versus advanced pelvic floor exercises to treat urinary incontinence after radical prostatectomy: a study protocol
Mina, D. S., Au, D., Alibhai, S. M. H., Jamnicky, L., Faghani, N., Hilton, W. J., Stefanyk, L. E., Ritvo, P., Jones, J. M., Elterman, D., et al. (2015) · BMC Urology · doi:10.1186/s12894-015-0088-4 · Cited by 41
“UI will be assessed using the 24-hour pad test, a 3-day, bladder diary, and a single-item on the Patient-Oriented Prostate Utility Scale (PORPUS).”
MethodInfluential
The Effect on Bone Outcomes of Home-based Exercise Intervention for Prostate Cancer Survivors Receiving Androgen Deprivation Therapy
Kim, S. H., Seong, D. H., Yoon, S. M., Choi, Y. D., Choi, E., Song, Y., & Song, H. (2017) · Cancer Nursing · doi:10.1097/ncc.0000000000000530 · Cited by 38
The association between health-related quality-of-life scores and clinical outcomes in metastatic castration-resistant prostate cancer patients: Exploratory analyses of AFFIRM and PREVAIL studies
Beer, T. M., Miller, K., TOMBAL, B. F., Cella, D. F., Phung, D., Holmström, S., Ivanescu, C., Skaltsa, K., & Naidoo, S. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2017.09.035 · Cited by 39
Self-citation
PREVALENCE OF FATIGUE AND IMPACT ON QUALITY OF LIFE IN CASTRATION-RESISTANT PROSTATE CANCER PATIENTS: the VITAL study
Rodríguez-Antolín, A., Martínez‐Piñeiro, L., Romero, M. E. J., Ramos, J. B. G., Bellido, D. L., del Toro, J. M., García-Porrero, Á. G., & Veiga, F. G. (2019) · BMC Urology · doi:10.1186/s12894-019-0527-8 · Cited by 38
Improving research for prostate cancer survivorship: A statement from the Survivorship Research in Prostate Cancer (SuRECaP) working group
Narayan, V., Harrison, M. R., Cheng, H. H., Kenfield, S. A., Aggarwal, R. R., Kwon, D. H.-M., McKay, R. R., Hauger, R. L., Hart, N. H., Conzen, S. D., et al. (2019) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2019.10.006 · Cited by 40
A randomized phase II study of cediranib alone versus cediranib in combination with dasatinib in docetaxel resistant, castration resistant prostate cancer patients
Spreafico, A., Chi, K. N., Sridhar, S. S., Smith, D. C., Carducci, M. A., Kavsak, P. A., Wong, T., Wang, L. E., Ivy, S. P., Mukherjee, S. D., et al. (2014) · Investigational New Drugs · doi:10.1007/s10637-014-0106-5 · Cited by 38
“To assess Quality of Life (QoL), patients also completed both FACT-P and PPI questionnaires [57, 58].”
Method
Quality of life impact of three different doses of suramin in patients with metastatic hormone‐refractory prostate carcinoma
Ahles, T. A., Herndon, J. E., Small, E. J., Vogelzang, N. J., Kornblith, A. B., Ratain, M. J., Stadler, W. M., Palchak, D., Marshall, M. E., Wilding, G., et al. (2004) · Cancer · doi:10.1002/cncr.20655 · Cited by 37
The Validity and Utility of the MD Anderson Symptom Inventory in Patients With Prostate Cancer: Evidence From the Symptom Outcomes and Practice Patterns (SOAPP) Data From the Eastern Cooperative Oncology Group
Jones, D., Zhao, F., Fisch, M. J., Wagner, L. I., Patrick‐Miller, L. J., Cleeland, C. S., & Mendoza, T. R. (2013) · Clinical Genitourinary Cancer · doi:10.1016/j.clgc.2013.07.003 · Cited by 37
Prostate Cancer: Epidemiology and Health-related Quality of Life
Penson, D. F., Rossignol, M., Sartor, O. A., Scardino, P. T., & Abenhaim, L. L. (2008) · Urology · doi:10.1016/j.urology.2008.10.006 · Cited by 37
Impact of Enzalutamide Compared with Bicalutamide on Quality of Life in Men with Metastatic Castration-resistant Prostate Cancer: Additional Analyses from the TERRAIN Randomised Clinical Trial
Heidenreich, A., Chowdhury, S., Klotz, L. H., Siemens, D. R., Villers, A. A., Ivanescu, C., Holmström, S., Baron, B., Wang, F., Lin, P., et al. (2016) · European Urology · doi:10.1016/j.eururo.2016.07.027 · Cited by 37
“FACT-P Physical well-being 11.1 (8.3–16.6) 11.1 (8.3–24.9) 1.06 (0.77–1.48) 0.7 Functional well-being 11.1 (8.3–13.8) 8.3 (5.6–11.0) 0.75 (0.55–1.03) 0.07 Emotional well-being 22.1 (14.3–NC) 11.1 (9.3–NC) 0.81 (0.56–1.18) 0.3 Social well-being 22.1 (14.1–NC) 11.8 (5.9–NC) 0.76 (0.53–1.09) 0.1 PCS 8.3 (5.6–11.0) 5.7 (5…”
MethodInfluential
Health-Related Quality of Life After the Diagnosis of Locally Advanced or Advanced Prostate Cancer
Zajdlewicz, L., Hyde, M. K., Lepore, S. J., Gardiner, R. A., & Chambers, S. K. (2017) · Cancer Nursing · doi:10.1097/ncc.0000000000000432 · Cited by 37
Evaluating a psychosocial intervention for men with prostate cancer and their partners: Outcomes and lessons learned from a randomized controlled trial
McCaughan, E., Curran, C., Northouse, L., & Parahoo, K. (2018) · Applied Nursing Research · doi:10.1016/j.apnr.2018.01.008 · Cited by 38
Assessing the effect of patient navigator assistance for psychosocial support services on health‐related quality of life in a randomized clinical trial in Latino breast, prostate, and colorectal cancer survivors
Ramírez, A. G., Choi, B. Y., Muñoz, E., Perez, A., Gallion, K. J., Moreno, P. I., & Penedo, F. J. (2019) · Cancer · doi:10.1002/cncr.32626 · Cited by 37
A Measure of Health-Related Quality of Life Among Patients with Localized Prostate Cancer: Results from Ongoing Scale Development
Befort, C. A., Zeléfsky, M. J., Scardino, P. T., Borrayo, E. A., Giesler, R. B., & Kattan, M. W. (2005) · Clinical Prostate Cancer · doi:10.3816/cgc.2005.n.017 · Cited by 37
A real-world study assessing the use of bone-targeted agents and their impact on bone metastases in patients with prostate cancer treated in clinical practice in Europe
Body, J., von Moos, R., Rider, A., Hallworth, P., Bhowmik, D., Gatta, F., Hechmati, G., & Qian, Y. (2018) · Journal of bone oncology · doi:10.1016/j.jbo.2018.100212 · Cited by 37
Sexual health and treatment-related sexual dysfunction in sexual and gender minorities with prostate cancer
Dickstein, D. R., Edwards, C. R., Lehrer, E. J., Tarras, E. S., Gallitto, M., Sfakianos, J. P., Galsky, M. D., Stock, R. G., Safer, J. D., Rosser, B. R. S., et al. (2023) · Nature Reviews Urology · doi:10.1038/s41585-023-00778-3 · Cited by 41
Early Prostate Cancer: Prevention, Treatment Modalities, and Quality of Life Issues
Moul, J. W., Anderson, J., Penson, D. F., Klotz, L. H., Soloway, M. S., & Schulman, C. C. (2003) · European Urology · doi:10.1016/s0302-2838(03)00296-3 · Cited by 36
Impact of Lower Urinary Tract Symptoms on Quality of Life Using Functional Assessment Cancer Therapy Scale
Batista-Miranda, J. E., Molinuevo, B., & Pardo, Y. (2007) · Urology · doi:10.1016/j.urology.2006.09.054 · Cited by 35
Evaluation of quality of life after laparoscopic surgery
Korolija, D., Sauerland, S., Abbou, C. C., Eypasch, E. P., Lumsden, M. A., Millat, B., Monson, J. R. T., Nilsson, G., Pointner, R., Schwenk, W., et al. (2004) · Cited by 35
A systematic review of disease related stigmatization in patients living with prostate cancer
Larkin, D., Birtle, A. J., Bradley, L., Dey, P., Martin, C. R., Pilkington, M., & Romero-Rivas, C. (2022) · PLoS ONE · doi:10.1371/journal.pone.0261557 · Cited by 37
Focal Salvage MR Imaging–Guided Cryoablation for Localized Prostate Cancer Recurrence after Radiotherapy: 12-Month Follow-up
Bomers, J. G. R., Overduin, C. G., Jenniskens, S. F. M., Cornel, E. B., van Lin, E. N. J. T., Sedelaar, J. P. M., & Fütterer, J. J. (2019) · Journal of Vascular and Interventional Radiology · doi:10.1016/j.jvir.2019.07.001 · Cited by 34
Measuring Quality of Life in Cancer Survivors
Victorson, D. E., Cella, D. F., Wagner, L. I., Kramer, L. M. B., & Smith, M. L. (2007) · Springer eBooks · doi:10.1007/978-0-387-34562-8_6 · Cited by 36
Self-citation
Evaluación de la calidad de vida de los pacientes con cáncer de próstata localizado: validación de la versión española del cuestionario EPIC
Ferrer, M., Garín, O., Pera, J., Prats, J. M., Mendívil, J., Alonso, J., de Paula, B., Herruzo, I., Hervas, A., Macías, V., et al. (2009) · Medicina Clínica · doi:10.1016/j.medcli.2008.01.001 · Cited by 34
Proxy assessment of quality of life in patients with prostate cancer: how accurate are partners and urologists?
Pearcy, R., Waldron, D., O’Boyle, C. A., & MacDonagh, R. (2008) · Journal of the Royal Society of Medicine · doi:10.1258/jrsm.2008.081002 · Cited by 34
Quality of life in patients undergoing salvage procedures for locally recurrent prostate cancer
Tefilli, M. V., Gheiler, E. L., Tiguert, R., Barroso, U., Barton, C. D., Wood, D. P., & Pontes, J. E. (1998) · Journal of Surgical Oncology · doi:10.1002/(sici)1096-9098(199811)69:3 · Cited by 34
Quality of life in prostate cancer
Talcott, J. A., & Clark, J. A. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2004.12.030 · Cited by 34
“The FACT-P items assess urinary, bowel, and sexual function, three specific symptoms (weight, appetite and pain), and emotional role [70].”
Background
The effect of erectile dysfunction on quality of life following treatment for localized prostate cancer.
Penson, D. F. (2001) · Europe PMC (PubMed Central) · Cited by 34
QUALITY OF LIFE IN METASTATIC PROSTATE CANCER AMONG MEN OF LOWER SOCIOECONOMIC STATUS: FEASIBILITY AND CRITERION RELATED VALIDITY OF 3 MEASURES
Knight, S. J., Chmiel, J. S., Kuzel, T. M., Sharp, L. K., ALBERS, M., FINE, R., Moran, E. M., Nadler, R. B., Sharifi, R., & Bennett, C. L. (1998) · The Journal of Urology · doi:10.1016/s0022-5347(01)62401-7 · Cited by 34
Clinical Trial Protocol for VIOLET: A Single-Center, Phase I/II Trial Evaluation of Radioligand Treatment in Patients with Metastatic Castration-Resistant Prostate Cancer with [161Tb]Tb-PSMA-I&T
Buteau, J. P., Kostos, L. K., Alipour, R., Jackson, P. A., McInstosh, L., Emmerson, B., Haskali, M. B., Xie, J., Medhurst, E., Ravi, R., et al. (2024) · Journal of Nuclear Medicine · doi:10.2967/jnumed.124.267650 · Cited by 37
Cancer Patient and Survivor Research From the Cancer Information Service Research Consortium: A Preview of Three Large Randomized Trials and Initial Lessons Learned
Marcus, A. C., Diefenbach, M. A., Stanton, A. L., Miller, S. M., Fleisher, L. G., Raich, P. C., Morra, M. E., Perocchia, R. S., Tran, Z. V., & Bright, M. A. (2013) · Journal of Health Communication · doi:10.1080/10810730.2012.743629 · Cited by 33
“…assessments of functional health status, fatigue, vitality, and quality of life (Brady et al., 1997; Broadbent, Petrie, Main, & Weinman, 2006; Esper et al., 1997; Ganz, Day, Ware, Redmond, & Fisher, 1995; Ware, Kosinski, & Keller, 1996; Yellen Cella, Webster, Blendowski, & Kaplan, 1997).”
Health-related Quality of Life in Patients with Advanced Prostate Cancer: A Systematic Review
Kretschmer, A., Ploussard, G., Heidegger, I. M., Tsaur, I., Borgmann, H., Surcel, C. I., Mathiéu, R., Visschere, P. D., Valério, M., van den Bergh, R. C. N., et al. (2020) · European Urology Focus · doi:10.1016/j.euf.2020.01.017 · Cited by 34
Testosterone Levels and Quality of Life in Diverse Male Patients With Cancers Unrelated to Androgens
Fleishman, S. B., Khan, H., Homel, P., Suhail, M. F., Strebel-Amrhein, R., Mohammad, F., Mahajan, D., Rosenwald, V., Guarino, M. J., Mirzoyev, T., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.3818 · Cited by 34
Patient‐reported outcome ( PRO ) questionnaires for men who have radical surgery for prostate cancer: a conceptual review of existing instruments
Protopapa, E., van der Meulen, J., Moore, C. M., & Smith, S. C. (2017) · British Journal of Urology · doi:10.1111/bju.13896 · Cited by 33
Development, characteristics and validity of the EORTC QLQ-PR25 and the FACT-P for assessment of quality of life in prostate cancer patients
Chu, D., Popovic, M. M., Chow, E., Cella, D. F., Beaumont, J. L., Lam, H., Nguyen, J., Giovanni, J. D., Pulenzas, N., Bedard, G., et al. (2014) · Journal of Comparative Effectiveness Research · doi:10.2217/cer.14.41 · Cited by 32
Self-citation
eRADicAte: A Prospective Evaluation Combining Radium-223 Dichloride and Abiraterone Acetate Plus Prednisone in Patients With Castration-Resistant Prostate Cancer
Shore, N. D., Tutrone, R. F., Jr., Mariados, N. F., Nordquist, L. T., Mehlhaff, B. A., Steere, K. J., & Harrelson, S. S. (2017) · Clinical Genitourinary Cancer · doi:10.1016/j.clgc.2017.10.022 · Cited by 32
Longitudinal associations among quality of life and its predictors in patients treated for prostate cancer: The moderating role of age
Diefenbach, M. A., Mohamed, N., Horwitz, E. M., & Pollack, A. S. (2008) · Psychology Health & Medicine · doi:10.1080/13548500701352008 · Cited by 32
“We used the Functional Assessment of Cancer Therapy Scale Prostate Module (Esper et al., 1997) to assess patients’ QOL.”
Method
Docetaxel Followed by Hormone Therapy in Men Experiencing Increasing Prostate-Specific Antigen After Primary Local Treatments for Prostate Cancer
Hussain, A., Dawson, N. A., Amin, P. P., Engstrom, C. A., Dorsey, B., Siegel, E., & Guo, C. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.07.152 · Cited by 32
Patient-reported outcomes in metastatic castration-resistant prostate cancer
Fallowfield, L. J., Payne, H. A., & Jenkins, V. A. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.100 · Cited by 32
The role of mindfulness in distress and quality of life for men with advanced prostate cancer
Chambers, S. K., Foley, E., Clutton, S., McDowall, R., Occhipinti, S., Berry, M., Stockler, M. R., Lepore, S. J., Frydenberg, M., Gardiner, R. A., et al. (2016) · Quality of Life Research · doi:10.1007/s11136-016-1341-3 · Cited by 31
What is the minimal dose for resistance exercise effectiveness in prostate cancer patients? Systematic review and meta-analysis on patient-reported outcomes
López, P., Taaffe, D. R., Newton, R. U., Buffart, L. M., & Galvao, D. A. (2020) · Prostate Cancer and Prostatic Diseases · doi:10.1038/s41391-020-00301-4 · Cited by 33
Mapping FACT-P to EQ-5D in a large cross-sectional study of metastatic castration-resistant prostate cancer patients
Diels, J., Hamberg, P., Ford, D., Price, P. W., Spencer, M., & Dass, R. N. (2014) · Quality of Life Research · doi:10.1007/s11136-014-0794-5 · Cited by 31
Quality-of-Life Outcomes in Oncology
Siddiqui, F., Kachnic, L. A., & Movsas, B. (2006) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2006.01.003 · Cited by 31
Health-related quality of life effects of enzalutamide in patients with metastatic castration-resistant prostate cancer: an in-depth post hoc analysis of EQ-5D data from the PREVAIL trial
Devlin, N. J., Herdman, M. J., Pavesi, M., Phung, D., Naidoo, S., Beer, T. M., TOMBAL, B. F., Loriot, Y., Ivanescu, C., Parli, T., et al. (2017) · Health and Quality of Life Outcomes · doi:10.1186/s12955-017-0704-y · Cited by 31
Docetaxel Versus Surveillance After Radical Radiotherapy for Intermediate- or High-risk Prostate Cancer—Results from the Prospective, Randomised, Open-label Phase III SPCG-13 Trial
Kellokumpu‐Lehtinen, P., Hjälm-Eriksson, M., Karlsson, C. T., Åström, L., Franzén, L., Fransson, A.-S., Leskinen, M. J., Zeke, M., Huttunen, T., & Ginman, C. (2019) · European Urology · doi:10.1016/j.eururo.2019.08.010 · Cited by 32
A phase 2 randomized clinical trial of abiraterone plus ADT, apalutamide, or abiraterone and apalutamide in patients with advanced prostate cancer with non-castrate testosterone levels (LACOG 0415)
Maluf, F. C., Schutz, F. A., Cronemberger, E. H., Luz, M. D. A., Martins, S. P. S., Muniz, D. Q. B., Bastos, D. A., Cárcano, F. M., Smaletz, Ò., Soares, A., et al. (2021) · European Journal of Cancer · doi:10.1016/j.ejca.2021.08.032 · Cited by 30
Examining a Therapeutic Yoga Program for Prostate Cancer Survivors
Zahavich, A. N. R., Robinson, J. A., Paskevich, D. M., & Culos-Reed, S. N. (2012) · Integrative Cancer Therapies · doi:10.1177/1534735412446862 · Cited by 30
Social Support for Patients with Prostate Cancer
Poole, G., Poon, C. S., Achille, M. A., White, K., Franz, N., Jittler, S., Watt, K., Cox, D. N., & Doll, R. (2001) · Journal of Psychosocial Oncology · doi:10.1300/j077v19n02_01 · Cited by 30
“The FACT-P and its subscales demonstrated acceptable to high internal consistency and reliability (Cella et al., 1993; Esper et al., 1997), were sensitive to clinical changes over time, and were able to discriminate patients at different stages of disease (Esper et al., 1997).”
Background
RECOVERY OF HEALTH RELATED QUALITY OF LIFE IN THE YEAR AFTER RADICAL PROSTATECTOMY
Litwin, M. S., McGuigan, K. A., Shpall, A. I., & Dhanani, N. (1999) · The Journal of Urology · doi:10.1097/00005392-199902000-00043 · Cited by 30
Interest in services among prostate cancer patients receiving androgen deprivation therapy
Shapiro, P. J., Coyne, J. C., Kruus, L. K., Palmer, S. C., Vaughn, D. J., & Malkowicz, S. B. (2004) · Psycho-Oncology · doi:10.1002/pon.769 · Cited by 29
Experiences of symptoms in men with hormone refractory prostate cancer and skeletal metastases
Lindqvist, O., Rasmussen, B. H., & Widmark, A. (2008) · European Journal of Oncology Nursing · doi:10.1016/j.ejon.2008.03.003 · Cited by 29
“, 1993)—in addition to 12 PC specific items, the PC subscale (PCS), which includes items on weight and appetite, pain, comfort, ability to feel like a man and to have and maintain an erection, and bowel and urinary dysfunction (Esper et al., 1997).”
Background
Quality of life in patients with localized prostate cancer
Quek, M. L., & Penson, D. F. (2005) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2005.03.003 · Cited by 29
Brief assessment of priority symptoms in hormone refractory prostate cancer: the FACT Advanced Prostate Symptom Index (FAPSI).
Yount, S., Cella, D. F., Banik, D., Ashraf, T., & Shevrin, D. H. (2003) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-1-69 · Cited by 29
Self-citation
The Functional Assessment of Cancer Therapy-Prostate (FACT-P) Scales in Men with Prostate Cancer: Reliability and Validity of the Korean Version
Hong, J. H., Jeon, S. S., Lee, H. M., Choi, Y. H., Kim, S., & Choi, H. Y. (2006) · Journal of Korean Medical Science · doi:10.3346/jkms.2006.21.2.295 · Cited by 29
Quality of life in patients with prostate cancer
McPherson, C. P., Swenson, K. K., & Kjellberg, J. L. (2001) · Seminars in Oncology Nursing · doi:10.1016/s0749-2081(01)80021-8 · Cited by 29
Defining an international research agenda for quality of life in men with prostate cancer
Litwin, M. S., Fitzpatrick, J. M., Fosså, S. D., & Newling, D. (1999) · The Prostate · doi:10.1002/(sici)1097-0045(19990915)41:1 · Cited by 29
Quality of life in low-income patients with metastatic prostate cancer: Divergent and convergent validity of three instruments
Sharp, L. K., Knight, S. J., Nadler, R. B., ALBERS, M., Moran, E. M., Kuzel, T. M., Sharifi, R., & Bennett, C. L. (1999) · Quality of Life Research · doi:10.1023/a:1008940015696 · Cited by 29
“We found that the EORTC and the FACT had Cronbach alpha internal consistency reliability coeAcients that were generally consistent with prior published reports [13, 33, 34 ].”
BackgroundResultInfluential
Does low volume high-intensity interval training elicit superior benefits to continuous low to moderate-intensity training in cancer survivors?
Toohey, K. L., Pumpa, K. L., McKune, A. J., Cooke, J., DuBose, K. D., Yip, D., Craft, P., & Semple, S. (2018) · World Journal of Clinical Oncology · doi:10.5306/wjco.v9.i1.1 · Cited by 28
Evaluating health-related quality of life and priority health problems in patients with prostate cancer: A strategy for defining the role of the advanced practice nurse
Bryant‐Lukosius, D., Browne, G. B., DiCenso, A., Whelan, T. J., Gafni, A., Neville, A. J., & Sathya, J. (2010) · Canadian Oncology Nursing Journal · doi:10.5737/1181912x201514 · Cited by 27
The quality of life of men with locally advanced prostate cancer during neoadjuvant hormone therapy: data from the Medical Research Council RT01 trial (ISRCTN 47772397)
Stephens, R. J., Dearnaley, D. P., Cowan, R. A., Sydes, M. R., Naylor, S., Fallowfield, L. J., & collaborators, O. B. O. A. T. R. (2006) · British Journal of Urology · doi:10.1111/j.1464-410x.2006.06560.x · Cited by 28
Symptoms and Impacts in Non-Metastatic Castration-Resistant Prostate Cancer: Qualitative Study Findings
Tomaszewski, E. L., Moïse, P., Krupnick, R. N., Downing, J., Meyer, M. H., Naidoo, S., & Holmström, S. (2017) · Patient · doi:10.1007/s40271-017-0227-y · Cited by 28
HEALTH RELATED QUALITY OF LIFE ASSESSMENT AFTER RADICAL PROSTATECTOMY IN MEN WITH PROSTATE SPECIFIC ANTIGEN ONLY RECURRENCE
Pietrow, P. K., Parekh, D. J., Smith, J. A. J., Shyr, Y., & Cookson, M. S. (2001) · The Journal of Urology · doi:10.1016/s0022-5347(05)65552-8 · Cited by 28
Evaluation of quality of life in patients with previously untreated advanced prostate cancer receiving maximum androgen blockade therapy or LHRHa monotherapy: a multicenter, randomized, double-blind, comparative study
Arai, Y., Akaza, H., Deguchi, T., Fujisawa, M., Hayashi, M., Hirao, Y., Kanetake, H., Naito, S., Namiki, M., Tachibana, M., et al. (2008) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-008-0409-z · Cited by 28
“Quality of life was evaluated at baseline and at weeks 1, 5, and 24 of treatment in both groups using the Japanese version (Hinotsu et al. 1999) of the Functional Assessment of Cancer Therapy-Prostate (FACT-P) questionnaire ( Esper et al. 1997 ).”
Method
Effects of resistance training frequency on physical functioning and quality of life in prostate cancer survivors: a pilot randomized controlled trial
Norris, M. K., Bell, G. J., North, S. A., & Courneya, K. S. (2015) · Prostate Cancer and Prostatic Diseases · doi:10.1038/pcan.2015.28 · Cited by 27
Analysis Linking UCLA PCI With Expanded Prostate Cancer Index Composite: An Evaluation of Health Related Quality of Life in Japanese Men With Localized Prostate Cancer
Namiki, S., Takegami, M., Kakehi, Y., Suzukamo, Y., Fukuhara, S., & Arai, Y. (2007) · The Journal of Urology · doi:10.1016/j.juro.2007.03.113 · Cited by 27
Quality of Life with Advanced Metastatic Prostate Cancer
Resnick, M. J., & Penson, D. F. (2012) · Urologic Clinics of North America · doi:10.1016/j.ucl.2012.07.007 · Cited by 27
Cancer-Specific Concerns and Physical Activity Among Recently Diagnosed Breast and Prostate Cancer Survivors
Ottenbacher, A. J., Sloane, R. J., Snyder, D. C., Kraus, W. E., Sprod, L. K., & Demark‐Wahnefried, W. (2012) · Integrative Cancer Therapies · doi:10.1177/1534735412449734 · Cited by 28
“Both the FACT-B and FACT-P are reliable and valid instruments for assessment of cancer-specific concerns and quality of life among breast and prostate cancer survivors, respectively.(7,8)”
BackgroundMethod
Religion and spirituality among patients with localized prostate cancer
Hamrick, N., & Diefenbach, M. A. (2006) · Palliative & Supportive Care · doi:10.1017/s1478951506060457 · Cited by 30
Patient-reported outcome labeling claims and measurement approach for metastatic castration-resistant prostate cancer treatments in the United States and European Union
Clark, M., Harris, N., Griebsch, I., Kaschinski, D., & Copley‐Merriman, C. (2014) · Health and Quality of Life Outcomes · doi:10.1186/s12955-014-0104-5 · Cited by 26
Quality of Life Associated with Treatment of Castration-Resistant Prostate Cancer: A Review of the Literature
Moul, J. W., & Dawson, N. A. (2012) · Cancer Investigation · doi:10.3109/07357907.2011.629381 · Cited by 26
A Model of Consultation in Prostate Cancer Care
Paterson, C. C., & Nabi, G. (2016) · Cancer Nursing · doi:10.1097/ncc.0000000000000404 · Cited by 26
Ambulatory Robot-Assisted Laparoscopic Prostatectomy: Is It Ready for Prime Time? A Quality of Life Analysis
Bajpai, R. R., Razdan, S., Barack, J., Sanchez, M. A., & Razdan, S. (2019) · Journal of Endourology · doi:10.1089/end.2019.0261 · Cited by 26
Should function and bother be measured and reported separately for prostate cancer quality-of-life domains?
Reeve, B. B., Potosky, A. L., & Willis, G. (2006) · Urology · doi:10.1016/j.urology.2006.03.037 · Cited by 25
Religious Coping and Quality of Life Among Black and White Men With Prostate Cancer
Bruce, M. A., Bowie, J. V., Barge, H., Beech, B. M., LaVeist, T. A., Howard, D. L., & Thorpe, R. J. (2020) · Cancer Control · doi:10.1177/1073274820936288 · Cited by 25
A reference set of health utilities for long-term survivors of prostate cancer: population-based data from Ontario, Canada
Krahn, M. D., Bremner, K. E., Alibhai, S. M. H., Ni, A., TOMLINSON, G. A., Laporte, A., & Naglie, G. (2013) · Quality of Life Research · doi:10.1007/s11136-013-0401-1 · Cited by 25
A phase II RCT and economic analysis of three exercise delivery methods in men with prostate cancer on androgen deprivation therapy
Alibhai, S. M. H., Mina, D. S., Ritvo, P., Sabiston, C. M., Krahn, M. D., TOMLINSON, G. A., Matthew, A., SEGAL, R. J., Warde, P. R., Durbano, S., et al. (2015) · BMC Cancer · doi:10.1186/s12885-015-1316-8 · Cited by 27
United in Fight against prOstate cancer (UFO) registry: first results from a large, multi‐centre, prospective, longitudinal cohort study of advanced prostate cancer in Asia
Uemura, H., Ye, D., Kanesvaran, R., Chiong, E., Lojanapiwat, B., Pu, Y., Rawal, S. K., Razack, A. H. A., Zeng, H., Chung, B. H., et al. (2019) · British Journal of Urology · doi:10.1111/bju.14980 · Cited by 25
Efficacy of a multi-component exercise programme and nutritional supplementation on musculoskeletal health in men treated with androgen deprivation therapy for prostate cancer (IMPACT): study protocol of a randomised controlled trial
Owen, P. J., Daly, R. M., Livingston, P. M., Mundell, N. L., Via, J. D., Millar, J. L., & Fraser, S. F. (2017) · Trials · doi:10.1186/s13063-017-2185-z · Cited by 24
“We will also have sufficient sample to detect a clinically meaningful difference of 0.5 SD in the Assessment of Quality of Life 8D questionnaire (AQoL8D) and 9 points on the FACT-P (disease-specific QoL).”
MethodInfluential
High-intensity interval training or resistance training versus usual care in men with prostate cancer on active surveillance: a 3-arm feasibility randomized controlled trial
Papadopoulos, E., Gillen, J. B., Moore, D., Au, D., Kurgan, N., Klentrou, P., Finelli, A., Alibhai, S. M. H., & Mina, D. S. (2021) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2021-0365 · Cited by 25
Exercise interventions for adults with cancer receiving radiation therapy alone
Trommer, M., Marnitz, S., Skoetz, N., Rupp, R., Niels, T., Morgenthaler, J., Theurich, S., von Bergwelt‐Baildon, M., Baues, C., & Baumann, F. T. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013448.pub2 · Cited by 22
Detailed analysis of patient-reported lower urinary tract symptoms and effect on quality of life after robotic radical prostatectomy
Aning, J. J., MacKenzie, K. R., Fabricius, M. J., McColl, E., Johnson, M. I., Tandoğdu, Z., Soomro, N., & Harding, C. (2018) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2018.05.017 · Cited by 24
Quality of life in men receiving radiotherapy and neo‐adjuvant androgen deprivation for prostate cancer: results from a prospective longitudinal study
Mc Caughan, E., Mc Sorley, O., Prue, G., Parahoo, K., Bunting, B., Sullivan, J. O., & McKenna, H. (2013) · Journal of Advanced Nursing · doi:10.1111/j.1365-2648.2012.05987.x · Cited by 23
“The FACT-P focuses less on the specific side effects of prostate cancer treatment and more on the functional domains of quality of life (Esper et al. 1997).”
BackgroundMethod
A randomized controlled trial of a self-management psychosocial intervention for men with prostate cancer and their partners: a study protocol
McCaughan, E., Prue, G., McSorley, O., Northouse, L., Schafenacker, A., & Parahoo, K. (2013) · Journal of Advanced Nursing · doi:10.1111/jan.12132 · Cited by 23
Matching-Adjusted Indirect Comparison of Health-Related Quality of Life and Adverse Events of Apalutamide Versus Enzalutamide in Non-Metastatic Castration-Resistant Prostate Cancer
Chowdhury, S., Oudard, S. M., Uemura, H., Joniau, S., Pilon, D., Lefèbvre, P., McQuarrie, K., Liu, J., Dearden, L., Sermon, J., et al. (2019) · Advances in Therapy · doi:10.1007/s12325-019-01157-4 · Cited by 23
Creation and Psychometric Validation of the Sexual Minorities and Prostate Cancer Scale (SMACS) in Sexual Minority Patients-The Restore-2 Study
Polter, E. J., Kohli, N., Rosser, B. R. S., Talley, K. M., Wheldon, C. W., Hoefer, C. J., Wright, M., Haggart, R. C., Mitteldorf, D., Kilian, G., et al. (2022) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2021.12.012 · Cited by 23
Quality of Life–Focused Decision-Making for Prostate Cancer
Shevach, J. W., Weiner, A. B., & Morgans, A. K. (2019) · Current Urology Reports · doi:10.1007/s11934-019-0924-2 · Cited by 25
Gesundheitsbezogene Lebensqualität – ein zentraler patientenrelevanter Endpunkt in der Nutzenbewertung medizinischer Maßnahmen
Bullinger, M., Blome, C., Sommer, R., Lohrberg, D., & Augustin, M. (2015) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/s00103-014-2107-0 · Cited by 23
Hot Flashes During Androgen Deprivation Therapy With Luteinizing Hormone-Releasing Hormone Agonist Combined With Steroidal or Nonsteroidal Antiandrogen for Prostate Cancer
Sakai, H., Igawa, T., Tsurusaki, T., Yura, M., Kusaba, Y., Hayashi, M., Iwasaki, S., Hakariya, H., Hara, T., & Kanetake, H. (2008) · Urology · doi:10.1016/j.urology.2008.09.013 · Cited by 22
Quality of life following definitive therapy for localized prostate cancer: potential impact of multiple therapies
Litwin, M. S. (2003) · Current Opinion in Urology · doi:10.1097/00042307-200303000-00011 · Cited by 23
Adoption, Acceptability, and Effectiveness of a Mobile Health App for Personalized Prostate Cancer Survivorship Care: Protocol for a Realist Case Study of the Ned App
Pham, Q., Cafazzo, J. A., & Feifer, A. (2017) · JMIR Research Protocols · doi:10.2196/resprot.8051 · Cited by 22
“Patients will have scheduled monthly PROMs, specifically the Expanded Prostate Cancer Index Composite (EPIC-26) [39] and the Functional Assessment of Cancer Therapy-Prostate [40], to measure their prostate cancer-specific quality of life.”
A randomised controlled trial to evaluate the efficacy of a 6 month dietary and physical activity intervention for prostate cancer patients receiving androgen deprivation therapy
Haseen, F., Murray, L., O'Neill, R. F., O’Sullivan, J. M., & Cantwell, M. M. (2010) · Trials · doi:10.1186/1745-6215-11-86 · Cited by 22
“It has been considered a reliable instrument with sensitivity to change in prostate specific antigen (PSA) scores and performance status [23].”
Quality of Life in Men Treated With Carbon Ion Therapy for Prostate Cancer
Wakatsuki, M., Tsuji, H., Ishikawa, H., Yanagi, T., Kamada, T., Nakano, T., Suzuki, H., Akakura, K., Shimazaki, J., & Tsujii, H. (2008) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2008.02.035 · Cited by 22
Comparison of Validated Instruments Measuring Sexual Function in Men
Levinson, A. W., Ward, N. T., Sanda, M. G., Mettee, L. Z., Wei, J. T., Su, L.-M., Litwin, M. S., & Pavlovich, C. P. (2010) · Urology · doi:10.1016/j.urology.2010.04.033 · Cited by 22
Role of Quality of Life in Men with Metastatic Hormone-Refractory Prostate Cancer: How Does Atrasentan Influence Quality of Life?
Cella, D. F., Petrylak, D. P., Fishman, M., Teigland, C. M., Young, J. M., & Mulani, P. M. (2006) · European Urology · doi:10.1016/j.eururo.2005.12.058 · Cited by 22
“Widely used prostate cancer-specific QOL instruments include the Functional Assessment of Cancer Therapy-Prostate (FACT-P) [16] and the Prostate Cancer Specific Quality of Life Instrument (PROSQOLI) [17].”
BackgroundMethodSelf-citation
Extending the validity of the Memorial Anxiety Scale for Prostate Cancer (MAX‐PC) at the time of prostate biopsy in a racially‐mixed population
Dale, W., Hemmerich, J. A., & Meltzer, D. O. (2006) · Psycho-Oncology · doi:10.1002/pon.1107 · Cited by 22
“Many men express feelings of stress, worry, and anxiety while dealing with prostate cancer and its treatments [3], leading to the development of validated tools to measure their impact on quality of life [4, 5].”
Background
Prostate Cancer in the Elderly
Konstantinos Hatzimouratidis, A. (2005) · International Urology and Nephrology · doi:10.1007/s11255-005-0402-2 · Cited by 22
A pilot investigation of a multidisciplinary quality of life intervention for men with biochemical recurrence of prostate cancer
Ames, S. C., Tan, W. W., Ames, G. E., Stone, R. L., Rizzo, T. D., Crook, J. E., Williams, C. R., Werch, C. E., Clark, M. M., & Rummans, T. A. (2011) · Psycho-Oncology · doi:10.1002/pon.1769 · Cited by 21
Comparison of Health-related Quality of Life Between Cancer Survivors Treated in Designated Cancer Centers and the General Public in Korea
Lee, J.-A., Kim, S.-Y., Kim, Y., Oh, J., Kim, H. J., Jo, D., Kwon, T.-G., & Park, J. (2013) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyt184 · Cited by 21
Cognition and depression effects of androgen receptor axis-targeted drugs in men with prostate cancer: A systematic review
Batra, A., Marchioni, M., Hashmi, A. Z., Lonergan, P. E., Morgans, A. K., Nead, K. T., Nguyen, P. L., Winquist, E., & Chin, J. L. (2020) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2020.11.002 · Cited by 22

Authors: Esper, P., Mo, F., Chodak, G., Sinner, M., Cella, D., & Pienta, K. J.
Affiliations: Rush University Medical Center (US)
Corresponding author: Esper, Peg
ORCID: Cella, David
Pienta, Kenneth J.
Venue: Urology
Publisher: Elsevier BV
Published: 1997-12
Volume: 50
Issue: 6
Pages: 920-928
ISSN: 0090-4295 (ISSN-L)
DOI: 10.1016/s0090-4295(97)00459-7
OpenAlex: W2004909463
Cited by: 696
References: 22
Citations by year: 2026: 18 · 2025: 22 · 2024: 34 · 2023: 25 · 2022: 45 · 2021: 34 · 2020: 20 · 2019: 31 · 2018: 35 · 2017: 29 · 2016: 33 · 2015: 30 · 2014: 28 · 2013: 31 · 2012: 27
FWCI: 4.00
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Urology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Oncology › Cancer survivorship and care
Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
Keywords: prostate cancer, quality of life, Functional Assessment of Cancer Therapy, questionnaire development, concurrent validity, internal consistency, sensitivity to change, prostate-specific antigen, performance status, disease stage
MeSH terms: Aged, Aged, 80 and over, Chicago, Humans, Male, Michigan, Middle Aged, Prostatic Neoplasms, Quality of Life, Surveys and Questionnaires, Sensitivity and Specificity, Reproducibility of Results

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Measuring quality of life in men with prostate cancer using the Functional Assessment of Cancer Therapy-prostate instrument

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Citations

Cites

Cited by

Related

Metadata

Record

About these checks